Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Coherus BioSciences, Inc. News

FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.

Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.

Five Below, Splunk, Snap: 'Mad Money' Lightning Round

Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.

The One-and-Wait Plan: Cramer's 'Mad Money' Recap

Jim Cramer's got a plan: Fed Chairman Jay Powell should hike once, then wait -- and maintain the independence of the Fed.

Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Even with Monday's sharp reversal, Jim Cramer says he still likes this market.

Biotech Movers: Acceleron, Clovis, Coherus

Acceleron Pharma, Clovis Oncology and Coherus BioSciences premarket trading on Tuesday.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.